In our case, immunohistochemical marker analysis of the tumor with the antibodies MPO, CD34, and CD117 proves the myeloid origin, parallel to Qian et al. [4], who noted that the positivity of the marker MPO was unparalleled. This evidence concerns the gene MPO and neoplasm.